In addition, expression of ENO2 was reportedly linked to prognosis for several cancers, including colorectal cancer (Pan et al., 2020), lung cancer (Liu et al., 2020), and pancreatic cancer (Zheng et al., 2020). Here, ENO2 is linked to familial pancreatic carcinoma.